American Society of Clinical Oncology (ASCO)

ASCO Daily News

Health EN ↓ 110 episodes

The ASCO Daily News Podcast features oncologists discussing the latest research and therapies in their areas of expertise.

Be sure to visit the podcast's website and support the creator: sites.libsyn.com

Author

American Society of Clinical Oncology (ASCO)

Category

Health

Podcast website

sites.libsyn.com

Latest episode

Nov 19, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 10M+ downloads · 4.7+ rating iOS soon

Episodes

Beyond One-Size-Fits-All: Personalizing Therapies for Gynecologic Cancer 19.11.2026

Dr. Shannon Westin joins Dr. Monty Pal to explore the evolving role of biomarkers, ctDNA, mismatch repair status, ADCs, and emerging therapies in gynecologic oncology. LINK TO FULL TRANSCRIPT

Cellular Immunotherapy at 10 Years: Lessons From Tisa-Cel 05.11.2026

Dr. Marco Ruella joins Dr. Monty Pal to discuss landmark 10-year follow-up data on tisa-cel CAR T-cell therapy for B-cell lymphomas, as well as emerging advances in dual-targeted CARs and their shift into earlier lines of treatment. LINK TO FULL TRANSCRIPT    

Highlights From the 2026 ASCO Quality Care Symposium w/ Dr. Ryan Nipp 29.10.2026

Dr. Ryan Nipp joins Dr. Monty Pal to discuss the high-impact cancer care delivery research presented at the 2026 ASCO Quality Care Symposium, including studies on financial navigation and decentralized clinical trials. LINK TO FULL TRANSCRIPT

ASCENT and DESTINY-Breast09 Trials: Applying Frontline Data in Metastatic Breast Cancer Care 15.10.2026

Dr. Sara Tolaney joins Dr. Monty Pal to discuss optimizing the sequencing and combination of antibody-drug conjugates for metastatic HER2-positive and triple-negative breast cancer, as well as guidelines for managing serious toxicities like ILD and neutropenia. LINK TO FULL TRANSCRIPT

CAR T Cells and Bispecific Antibodies: Navigating the New Era in Multiple Myeloma Management 01.10.2026

Myeloma specialists Dr. Marc Braunstein and Dr. Rahul Banerjee join Dr. Monty Pal to discuss recent breakthroughs for patients with multiple myeloma, including expert advice on how to manage side effects and identify the right treatment among a series of novel immuno- and targeted therapies. LINK TO FULL TRANSCRIPT

Are We Curing Advanced Melanoma? A Conversation With Dr. Jedd Wolchok 10.09.2026

Dr. Jedd Wolchok, a pioneer in melanoma research, joins Dr. Monty Pal to break down practice-changing advances in the field, including landmark 10-year CheckMate-067 survival data, safer immunotherapy dosing, and the rise of neoadjuvant treatment. LINK TO FULL TRANSCRIPT  

Updates in Bladder Cancer: From Intravesical Breakthroughs to Managing Toxicities 03.09.2026

Dr. Monty Pal and Dr. Petros Grivas discuss the rapidly evolving management of bladder cancer, including key updates in non-muscle-invasive disease, the integration of novel therapies in the advanced setting, and practical strategies for managing toxicities in clinical practice. LINK TO FULL TRANSCRIPT

How Do We Translate ASCO26 Research Into Practice in Latin America? 20.08.2026

In part two of our miniseries on the global translation gap in oncology, host Dr. Monty Pal and Dr. Regina Barragán-Carrillo explore how ASCO26 Plenary breakthroughs can be adapted to clinical practice in Latin America. Together, they address real-world implementation challenges including delayed diagnoses, finite resource allocation, and access to precision diagnostics. LINK TO FULL TRANSCRIPT

GLP-1 Receptor Agonists in GI Cancers: Hype or Promise? 06.08.2026

Dr. Monty Pal and Dr. Rachna Shroff explore how GLP-1 receptor agonists impact progression and survival in GI cancers, examining current retrospective data, immune microenvironment biology, and the need for prospective trials. LINK TO FULL TRANSCRIPT

From Abstract to Action: Translating ASCO26 Research Into Global Practice 23.07.2026

How do we translate oncology breakthroughs into practice? In part one of a two-part miniseries, host Dr. Monty Pal and Dr. Atul Batra discuss the clinical realities, opportunities, and challenges of adapting ASCO26 Plenary findings into cancer care worldwide, using India's health care landscape as a blueprint for resource-limited settings. LINK TO FULL TRANSCRIPT  

Liquid Biopsy, AI, and Other Global Innovations From 2026 ASCO Breakthrough 09.07.2026

Dr. Monty Pal and Dr. Roselle De Guzman discuss key abstracts from the 2026 ASCO Breakthrough Meeting, including the real-world impact of liquid biopsies for early multi-cancer detection, AI applications in colorectal cancer screening, and how global advances in breast, esophageal, and small cell lung cancers translate directly to diverse patient populations in the Asia-Pacific region. LINK TO FUL...

Breast Cancer Highlights From ASCO26: OPTIMA, lidERA, and VIKTORIA-1 30.06.2026

Dr. Megan Kruse and Dr. Hope Rugo discuss practice-changing data in metastatic breast cancer and critical shifts in the treatment of early-stage disease that were presented at the 2026 ASCO Annual Meeting. LINK TO FULL TRANSCRIPT

GU Cancer Highlights From ASCO26: PROTEUS, TALAPRO-3, and RAMPART 25.06.2026

Dr. Neeraj Agarwal and Dr. Jeanny Aragon-Ching discuss high-impact abstracts in the treatment of prostate, bladder, and kidney cancers that were presented at the 2026 ASCO Annual Meeting. LINK TO FULL TRANSCRIPT

Immunotherapy Highlights From ASCO26: Cellular Therapy, Melanoma, and Skin Cancers 24.06.2026

Dr. Pauline Funchain and Dr. Allison Betof discuss practice-changing and paradigm-shifting abstracts in melanoma, Merkel cell carcinoma, and cellular therapies that were presented at the 2026 ASCO Annual Meeting. LINK TO FULL TRANSCRIPT

GI Cancer Highlights From ASCO26: RASolute-302, BREAKWATER, and More 23.06.2026

Dr. Nilo Azad and Dr. Aparna Parikh discuss high-impact studies in gastrointestinal cancers and other novel treatment approaches that were presented at the 2026 ASCO Annual Meeting. LINK TO FULL TRANSCRIPT

Hematologic Cancer Highlights From ASCO26: MajesTEC-9, frontMIND, and More 19.06.2026

Dr. Marc Braunstein and Dr. Adam Kittai highlight top research on hematologic malignancies from the 2026 ASCO Annual Meeting, including studies on lymphoid malignancies, multiple myeloma, and plasma cell disorders. LINK TO FULL TRANSCRIPT  

Lung Cancer Highlights From ASCO26: HARMONi-6, LIBRETTO-436, and More 18.06.2026

Dr. Christine Lovly and Dr. Vamsi Velcheti discuss practice-changing lung cancer data presented at the 2026 ASCO Annual Meeting, including key studies on squamous cell lung cancer, NSCLC, and SCLC. LINK TO FULL TRANSCRIPT

Day 5: Top Takeaways From ASCO26 02.06.2026

Dr. Monty Pal shares highlights from the final day of ASCO26, including new research on treating anemia in myelofibrosis, advances in RAS-mutated mCRC, novel therapies for AML, and a potentially practice-changing trial in TNBC. LINK TO FULL TRANSCRIPT

Day 4: Top Takeaways From ASCO26 01.06.2026

Dr. Monty Pal shares highlights from Day 4 of the 2026 ASCO Annual Meeting, including a much-anticipated study in hepatocellular carcinoma, new data in non–small cell lung cancer, and a key update in the treatment of Merkel cell carcinoma. LINK TO TRANSCRIPT

Day 3: Top Takeaways From ASCO26 31.05.2026

Dr. Monty Pal shares highlights from Day 3 of the 2026 ASCO Annual Meeting, including new research for the treatment of advanced CRC and mCRPC, TIL cell therapy in advanced non-uveal melanoma, and an ultra-low dose immunotherapy trial in head and neck squamous cell carcinoma. LINK TO FULL TRANSCRIPT

Day 2: Top Takeaways From ASCO26 30.05.2026

Dr. Monty Pal shares highlights from Day 2 of the 2026 ASCO Annual Meeting, including a practice-changing trial in renal cell carcinoma, advances in ER-positive, HER2-negative early breast cancer, and the use of olanzapine as an effective steroid-sparing alternative for chemo-induced nausea and vomiting in pediatric cancer. LINK TO FULL TRANSCRIPT

Day 1: Top Takeaways From ASCO26 29.05.2026

In the first episode of a special daily series during the 2026 ASCO Annual Meeting, Dr. Monty Pal discusses 3 abstracts, including a follow-up on the EV-302 study in urothelial carcinoma, a potential new treatment option for patients with PD-L1-positive advanced non–small cell lung cancer, and a novel psychosocial digital application that improves fatigue and distress in patients with multiple mye...

ASCO26 Preview: Novel Therapies and Innovations in Cancer Care 21.05.2026

Dr. Monty Pal and Dr. Jo Chien preview new research, hot topics, and emerging innovations in oncology that will be presented at the 2026 ASCO Annual Meeting. LINK TO FULL TRANSCRIPT

The Future of AI in Oncology: A Conversation With Google's AI Innovators 14.05.2026

Google DeepMind's Dr. Alan Karthikesalingam and Google research scientist Anil Palepu sit down with Dr. Monty Pal to discuss the potential of Articulate Medical Intelligence Explorer (AMIE), a large language model-based experimental medical AI system designed to augment clinical decision-making in oncology and beyond, as well as the future of AI-human collaboration and how it could reshape health...

'No Margin for Error': What to Know Before Implementing AI in Clinical Practice 16.04.2026

Dr. Monty Pal and Dr. Arturo Loaiza-Bonilla discuss the institutional risks in the use of artificial intelligence (AI) in clinical practice and how overreliance on AI could erode essential skills. They also highlight practical approaches, including routine "AI-off" drills, to help oncologists retain their decision-making agility. LINK TO FULL TRANSCRIPT

Listen to the ASCO Daily News podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.